Natalia Curto‐García
Royal Marsden NHS Foundation Trust(GB)Guy's and St Thomas' NHS Foundation Trust(GB)Clatterbridge Cancer Centre NHS Foundation Trust(GB)Royal Marsden Hospital(GB)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Eosinophilic Disorders and Syndromes, Hemoglobinopathies and Related Disorders, Acute Myeloid Leukemia Research
Most-Cited Works
- → Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial(2023)129 cited
- → High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib(2021)80 cited
- → MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis(2023)77 cited
- → Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review(2019)72 cited
- → Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases(2019)68 cited
- → Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia